A new Centers for Disease Control and Prevention report offers guidance on the preexposure use of the JYNNEOS smallpox and monkeypox vaccine for individuals at risk for occupational exposure to orthopoxviruses. The recommendations were made by the CDC’s Advisory Committee on Immunization Practices. The committee recommends preexposure vaccination for people who work in laboratories doing research on orthopoxviruses; people who work in clinical laboratories performing testing to diagnose orthopoxviruses, certain people responding to orthopoxvirus-related public health investigations; and health care personnel who care for patients infected with orthopoxviruses or administer the ACAM2000 vaccine.

Related News Articles

Headline
Candida auris fungal infections tripled in the United States between 2019 and 2021 to 1,471, including seven cases resistant to all antifungal treatments,…
Headline
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in…
Chairperson's File
March 12–18 is Patient Safety Awareness Week. While patient safety is a priority every day of the year for teams working at our nation’s hospitals and health…
Perspective
Ninety-five. That’s the number of mass shootings that have occurred in the United States during the first two months of this year, according to the Gun…
Headline
Northwell Health today hosted its fourth annual Gun Violence Prevention Forum to mobilize the collective efforts of executives, clinicians, researchers,…
Headline
The Food and Drug Administration Friday authorized for emergency use the first over-the-counter test to detect both flu and SARS-CoV-2, the virus that causes…